Match each patient's presenting laboratory profile with the most likely underlying pathophysiological diagnosis. All patients present with a primary hypokalemic metabolic alkalosis and a normal serum creatinine level.
- Serum 2.4 mEq/L, Serum 35 mEq/L, Urine 8 mEq/L, Blood pressure 102/64 mmHgCovert emesis (Extrarenal chloride loss)
- Serum 2.7 mEq/L, Serum 32 mEq/L, Urine 65 mEq/L, Urine ratio 0.02, Blood pressure 112/72 mmHgGitelman syndrome (Distal convoluted tubule defect)
- Serum 2.6 mEq/L, Serum 33 mEq/L, Urine 72 mEq/L, Urine ratio 0.28, Blood pressure 108/68 mmHgBartter syndrome (Thick ascending limb defect)
- Serum 3.0 mEq/L, Serum 31 mEq/L, Urine 58 mEq/L, Plasma Aldosterone/Renin ratio 45, Blood pressure 168/102 mmHgPrimary hyperaldosteronism (Autonomous mineralocorticoid excess)
Cevap
The normotensive patient with low urine chloride matches Covert emesis. The hypertensive patient matches Primary hyperaldosteronism. Between the two normotensive salt-wasters, the patient with hypocalciuria matches Gitelman syndrome, and the patient with hypercalciuria matches Bartter syndrome.
The correct matches require a systematic, multi-step interpretation of the laboratory panels. First, blood pressure divides the etiologies: hypertension suggests mineralocorticoid excess, isolating primary hyperaldosteronism. Next, urine chloride separates volume-contracted states attempting to intensely conserve chloride (covert emesis, mEq/L) from renal salt-wasting states ( mEq/L). Finally, urine calcium effectively differentiates the remaining tubulopathies: Bartter syndrome causes hypercalciuria (like loop diuretics), whereas Gitelman syndrome causes hypocalciuria (like thiazide diuretics).
Adım Adım Çözüm
Anahtar Kavram
Algorithm for evaluating hypokalemic metabolic alkalosis using blood pressure, urine chloride, and urine calcium.
Tahmini Süre:2m 30s